Navana Pharmaceuticals
Navana Pharmaceuticals posts 12% profit growth in Q1
Strong sales drive the rise in profit
Navana Pharmaceuticals receives approval for Tk 150 crore partial convertible bond
Navana Pharmaceuticals has received approval from the Bangladesh Securities and Exchange Commission (BSEC) to issue a partial convertible bond worth Tk 150 crore
Navana Pharma to invest Tk 145 crore for new production unit
Tk 132 crore will come from own funds, external sources and the rest from IPO
Navana Pharma posts 28.25% profit rise in January-March
Navana Pharmaceuticals Limited’s profit rose 28.25 per cent year-on-year to Tk 11.71 crore in the January-March quarter of the current financial year.
Navana Pharmaceuticals posts 12% profit growth in Q1
Strong sales drive the rise in profit
Navana Pharmaceuticals receives approval for Tk 150 crore partial convertible bond
Navana Pharmaceuticals has received approval from the Bangladesh Securities and Exchange Commission (BSEC) to issue a partial convertible bond worth Tk 150 crore
Navana Pharma to invest Tk 145 crore for new production unit
Tk 132 crore will come from own funds, external sources and the rest from IPO
Navana Pharma posts 28.25% profit rise in January-March
Navana Pharmaceuticals Limited’s profit rose 28.25 per cent year-on-year to Tk 11.71 crore in the January-March quarter of the current financial year.